NASDAQ: AXSMAxsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?
Insider buying vs selling
Have Axsome Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark Coleman | Director | 2025-09-08 | 287 | $127.30 | $36.54kBuy |
| Mark Coleman | Director | 2025-09-08 | 488 | $127.40 | $62.17kBuy |
| Mark Coleman | Director | 2025-09-08 | 800 | $127.20 | $101.76kBuy |
| Mark E. Saad | Director | 2025-09-05 | 9,127 | $125.07 | $1.14MSell |
| Mark E. Saad | Director | 2025-09-05 | 9,127 | $9.00 | $82.14kBuy |
| Roger Jeffs | Director | 2025-09-02 | 13,464 | $123.68 | $1.67MSell |
| Roger Jeffs | Director | 2025-08-29 | 20,000 | $121.27 | $2.43MSell |
| Roger Jeffs | Director | 2025-08-28 | 20,000 | $121.60 | $2.43MSell |
| Roger Jeffs | Director | 2025-08-27 | 20,000 | $122.30 | $2.45MSell |
| Roger Jeffs | Director | 2025-08-26 | 20,000 | $120.03 | $2.40MSell |
AXSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AXSM insiders and whales buy or sell their stock.
AXSM Shareholders
What type of owners hold Axsome Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Herriot Tabuteau | 14.73% | 7,351,729 | $870.59M | Insider |
| Antecip Capital LLC | 14.72% | 7,344,500 | $869.74M | Insider |
| Vanguard Group Inc | 7.91% | 3,945,020 | $467.17M | Institution |
| Blackrock Inc | 7.69% | 3,834,990 | $454.14M | Institution |
| Bvf Inc | 3.39% | 1,690,221 | $200.16M | Institution |
| Rtw Investments LP | 3.04% | 1,516,903 | $179.63M | Institution |
| Macquarie Group Ltd | 2.28% | 1,137,748 | $134.73M | Institution |
| Geode Capital Management LLC | 1.98% | 989,453 | $117.17M | Institution |
| Fmr LLC | 1.96% | 976,730 | $115.66M | Institution |
| State Street Corp | 1.92% | 958,503 | $113.51M | Institution |
AXSM vs Biotech Stocks
Axsome Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.